| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c07749fd35ea0d4191468a7c4102afd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f9bbbd98f2eaed32adaf0748ad97147 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-131 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-131
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2022-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74d70ab63a808d945e513d34e2c93e65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51d635ccbfff5ccc0b4a91d36a6dccfb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1f737576b45e39e39c943b4f3acdcd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df398c7acc3dcbca0415cfbc588ecb3a |
| publicationDate |
2022-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022196731-A1 |
| titleOfInvention |
Cancer cell growth inhibiting composition and processed food |
| abstract |
The phytol contained in watermelon sprouts is known to have a cancer cell growth inhibiting effect. The problem, however, is the amount ingested to inhibit cancer cell growth is large. A cancer cell growth inhibiting composition having a substance having a structure represented by formulas (1) through (6) as the main component has a cancer cell growth inhibiting effect one or more orders of magnitude greater than that of phytol. Like phytol, these substances are expected to have no effect on normal cells. Provision of an anticancer agent with few side effects can therefore be expected. |
| priorityDate |
2021-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |